Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection

Andrea Boschi, C. Tinelli, P. Ortolani, M. Arlotti

Research output: Contribution to journalArticle

Abstract

Objective: Our previous studies on CD4-guided therapy interruption (TI) showed that the durations of the first and second TIs were similar if antiretroviral therapy (ART) was resumed at a level of the CD4 cell count similar to or higher than the nadir CD4 T-cell count. Therefore, in a strategy of repeated CD4-guided TI, it is important to know which factors predict the time for the CD4 T-cell count to return to nadir (TRN). Methods: From a cohort of 125 patients who interrupted ART, 92 patients who reached a CD4 T-cell count similar to the nadir count were included in the study. Results: The median TRN was 12.3 months. In the multivariate analysis, younger age (P = 0.011), lower pre-ART HIV RNA (P = 0.022) and female gender (P = 0.045) were associated with a longer TRN. After TI there were 11 clinical events in the group of patients whose nadir CD4 count was >200 cells/μL. Most of these events occurred when the TI was prolonged beyond the TRN. Conclusions: The factors predicting the TRN were age, HIV RNA pre-ART and gender. Resumption of therapy at a CD4 cell count similar to the nadir CD4 count appears to protect against the development of clinical events. Given the observational nature of this study, no conclusions can be drawn regarding the possible application of TI in clinical practice.

Original languageEnglish
Pages (from-to)19-26
Number of pages8
JournalHIV Medicine
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

CD4 Lymphocyte Count
HIV Infections
T-Lymphocytes
Therapeutics
HIV
RNA
Observational Studies
Multivariate Analysis

Keywords

  • Age
  • Antiretroviral therapy
  • CD4 lymphocyte count
  • Sex

ASJC Scopus subject areas

  • Virology
  • Medicine(all)
  • Immunology

Cite this

Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection. / Boschi, Andrea; Tinelli, C.; Ortolani, P.; Arlotti, M.

In: HIV Medicine, Vol. 9, No. 1, 01.2008, p. 19-26.

Research output: Contribution to journalArticle

@article{f9954d06400d4f38869afd6d165a5dc5,
title = "Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection",
abstract = "Objective: Our previous studies on CD4-guided therapy interruption (TI) showed that the durations of the first and second TIs were similar if antiretroviral therapy (ART) was resumed at a level of the CD4 cell count similar to or higher than the nadir CD4 T-cell count. Therefore, in a strategy of repeated CD4-guided TI, it is important to know which factors predict the time for the CD4 T-cell count to return to nadir (TRN). Methods: From a cohort of 125 patients who interrupted ART, 92 patients who reached a CD4 T-cell count similar to the nadir count were included in the study. Results: The median TRN was 12.3 months. In the multivariate analysis, younger age (P = 0.011), lower pre-ART HIV RNA (P = 0.022) and female gender (P = 0.045) were associated with a longer TRN. After TI there were 11 clinical events in the group of patients whose nadir CD4 count was >200 cells/μL. Most of these events occurred when the TI was prolonged beyond the TRN. Conclusions: The factors predicting the TRN were age, HIV RNA pre-ART and gender. Resumption of therapy at a CD4 cell count similar to the nadir CD4 count appears to protect against the development of clinical events. Given the observational nature of this study, no conclusions can be drawn regarding the possible application of TI in clinical practice.",
keywords = "Age, Antiretroviral therapy, CD4 lymphocyte count, Sex",
author = "Andrea Boschi and C. Tinelli and P. Ortolani and M. Arlotti",
year = "2008",
month = "1",
doi = "10.1111/j.1468-1293.2008.00522.x",
language = "English",
volume = "9",
pages = "19--26",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection

AU - Boschi, Andrea

AU - Tinelli, C.

AU - Ortolani, P.

AU - Arlotti, M.

PY - 2008/1

Y1 - 2008/1

N2 - Objective: Our previous studies on CD4-guided therapy interruption (TI) showed that the durations of the first and second TIs were similar if antiretroviral therapy (ART) was resumed at a level of the CD4 cell count similar to or higher than the nadir CD4 T-cell count. Therefore, in a strategy of repeated CD4-guided TI, it is important to know which factors predict the time for the CD4 T-cell count to return to nadir (TRN). Methods: From a cohort of 125 patients who interrupted ART, 92 patients who reached a CD4 T-cell count similar to the nadir count were included in the study. Results: The median TRN was 12.3 months. In the multivariate analysis, younger age (P = 0.011), lower pre-ART HIV RNA (P = 0.022) and female gender (P = 0.045) were associated with a longer TRN. After TI there were 11 clinical events in the group of patients whose nadir CD4 count was >200 cells/μL. Most of these events occurred when the TI was prolonged beyond the TRN. Conclusions: The factors predicting the TRN were age, HIV RNA pre-ART and gender. Resumption of therapy at a CD4 cell count similar to the nadir CD4 count appears to protect against the development of clinical events. Given the observational nature of this study, no conclusions can be drawn regarding the possible application of TI in clinical practice.

AB - Objective: Our previous studies on CD4-guided therapy interruption (TI) showed that the durations of the first and second TIs were similar if antiretroviral therapy (ART) was resumed at a level of the CD4 cell count similar to or higher than the nadir CD4 T-cell count. Therefore, in a strategy of repeated CD4-guided TI, it is important to know which factors predict the time for the CD4 T-cell count to return to nadir (TRN). Methods: From a cohort of 125 patients who interrupted ART, 92 patients who reached a CD4 T-cell count similar to the nadir count were included in the study. Results: The median TRN was 12.3 months. In the multivariate analysis, younger age (P = 0.011), lower pre-ART HIV RNA (P = 0.022) and female gender (P = 0.045) were associated with a longer TRN. After TI there were 11 clinical events in the group of patients whose nadir CD4 count was >200 cells/μL. Most of these events occurred when the TI was prolonged beyond the TRN. Conclusions: The factors predicting the TRN were age, HIV RNA pre-ART and gender. Resumption of therapy at a CD4 cell count similar to the nadir CD4 count appears to protect against the development of clinical events. Given the observational nature of this study, no conclusions can be drawn regarding the possible application of TI in clinical practice.

KW - Age

KW - Antiretroviral therapy

KW - CD4 lymphocyte count

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=38349077057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349077057&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1293.2008.00522.x

DO - 10.1111/j.1468-1293.2008.00522.x

M3 - Article

C2 - 18199169

AN - SCOPUS:38349077057

VL - 9

SP - 19

EP - 26

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 1

ER -